Islet transplantation is increasingly used as a
therapy for human
type 1 diabetes mellitus. In our study, we investigated the effect of the
transplantation of a low number (n = 350) of pancreatic islets into the right liver part on the neighboring portal bile ducts. Male
streptozotocin- diabetic Lewis or autoimmune-diabetic BB/Pfd rats (n = 1065) were subdivided into 11 experimental groups. A few days after low-number
islet transplantation, cholangiocytes adjacent to the grafts showed an increase in proliferative activity. During the next 12-24 months, many peri-insular ductules progressed via
tumor-like cystic lesions to large cystic
cholangiomas, accompanied by a translocation of the
insulin receptor into the cytoplasm and an increase in expression of
insulin-related signaling
proteins (Insulin-receptor-substrate-1, Raf-1, Mek-1). After 24 months, 53% of rats with low-number
transplantation exhibited at least one
cholangioma >10 mm, significantly outnumbering
tumor development in the transplant-free left liver part and in any control group. No
cholangiocarcinomas emerged. A graft cell origin of the
tumors was excluded by Y chromosome in situ hybridization in cross-gender
transplantations. Conclusively, low-number intrahepatic
islet transplantation, most likely acting by permanent local
hyperinsulinism, leads to prolonged cholangiocellular proliferation in
streptozotocin- and in autoimmune-diabetic rats, resulting in the development of benign cystic
cholangiomas.